共 50 条
Access challenges to opioid use disorder treatment among individuals experiencing homelessness: Voices from the streets
被引:12
|作者:
Hsu, Michael
[1
,7
]
Jung, Olivia S.
[3
]
Kwan, Li Ting
[4
]
Jegede, Oluwole
[5
]
Martin, Bianca
[6
]
Malhotra, Aniket
[2
]
Suzuki, Joji
[6
]
机构:
[1] Greater Los Angeles VA Med Ctr, Dept Psychiat, Los Angeles, CA USA
[2] Emory Univ, Sch Med, Dept Psychiat, Atlanta, GA USA
[3] Univ Calif Los Angeles, Fielding Sch Publ Hlth, Dept Hlth Policy & Management, Los Angeles, CA USA
[4] Columbia Univ, Vagelos Coll Phys & Surg, New York, NY USA
[5] Yale Sch Med, Dept Psychiat, New Haven, CT USA
[6] Brigham & Womens Hosp, Div Addict Psychiat, Boston, MA USA
[7] 11301 Wilshire Blvd,Bldg 210A, Los Angeles, CA 90073 USA
来源:
JOURNAL OF SUBSTANCE USE & ADDICTION TREATMENT
|
2024年
/
157卷
关键词:
Medications for opioid use disorder;
Buprenorphine;
Health equity;
Treatment access;
Opioid use disorder;
CHOOSING BUPRENORPHINE;
PATIENT PERSPECTIVES;
METHADONE TREATMENT;
ADDICTION;
STIGMA;
RACE;
D O I:
10.1016/j.josat.2023.209216
中图分类号:
B849 [应用心理学];
学科分类号:
040203 ;
摘要:
Background: Achieving equitable access to medications for opioid use disorder (MOUD) such as buprenorphine is a pressing issue. Evidence suggests disparities in MOUD access based on race and socioeconomic status, further exacerbated by the COVID-19 pandemic. However, the drivers behind this access gap remain poorly understood. This study explores barriers to treatment access among individuals with opioid use disorder (OUD) experiencing homelessness.Methods: We interviewed 28 individuals in and around the Boston Public Health Commission (BPHC) Engagement Center, an area known for its high density of active substance use and homelessness. We asked about people's experiences, perceptions, and attitudes toward OUD treatment. We conducted a thematic analysis of our interview data.Results: Fifty-four percent of participants sampled were not prescribed MOUD. None of the participants reported having an active prescription of sublingual buprenorphine or buprenorphine/naloxone. White participants were more likely to have been prescribed buprenorphine in the past compared to participants of other races even in this socioeconomically homogeneous sample. Themes that emerged in our data included challenges to accessing MOUD due to reduced services during the COVID-19 pandemic, lost or stolen medications, fewer inpatient withdrawal management beds for women, transportation challenges, fear of adverse effects of MOUD, the perception that taking MOUD replaces one addiction for another, and community disapproval of MOUD. Participants also reported stigma and discrimination based on race, gender, and socioeconomic status. Conclusion: Systems and individual-level factors contribute to the MOUD treatment gap across race and socioeconomic status. The COVID-19 pandemic posed additional access challenges. This study provides important, actionable insights about the barriers faced by a particularly vulnerable population of individuals with OUD experiencing homelessness.
引用
收藏
页数:10
相关论文